Hepatitis Diagnostic Test Market Report

Hepatitis Diagnostic Test Market Analysis Report, By Diagnostic Tests {Blood Tests (Liver Function Assays, Immunoassays & Nucleic Acid Assays), Imaging Tests & Liver Biopsy}, By Region, And Segment Forecasts, 2014 - 2025

  • Published Date: Jan, 2018
  • Base Year for Estimate: 2016
  • Report ID: GVR-1-68038-449-9
  • Format: Electronic (PDF)
  • Historical Data: 2014-2016
  • Number of Pages: 90

Industry Insights

The global hepatitis diagnostic test market size was valued at USD 3.9 billion in 2016 and is expected to grow at a CAGR of 6.5% over the forecast period. Hepatitis is generally of two types namely, acute (lasts for less than six months) and chronic (lasts for longer period). Among all the types of Hepatitis (namely A, B, C, D, and E), of which A, B and C have the highest prevalence rate. 

As reported by the WHO, hepatitis is a prime cause of liver cancer, it results into approximately 80% of all liver cancer cases registered and kills around 1.4 million people annually. WHO also quotes globally 300 million people are infected with chronic type of hepatitis.

U.S. hepatitis diagnostics market

The spread of hepatitis occurs through various modes of transmission, showing wide range of symptoms in different population across geographies. The incidence rate of Hepatitis C and B is higher than that of A, D and E. Rising awareness and knowledge regarding the diagnosis and available treatment options is triggering the market growth.

Molecular diagnostics is an emerging technology adopted in diagnosis of the disease. It involves DNA, and RNA analysis for detection of the exact disease viruses using nucleic acid tests such as HBV DNA & HCV RNA analysis. Availability of these confirmatory checks is spurring the market growth for diagnosis and confirmation of the disease at an early stage.

Test Type Insights

The hepatitis diagnostics market is segmented on the basis of the major diagnostic assays used in detection and confirmation of the disease in the patients. The blood profiling dominates the sector and are expected to exhibit fastest growth rate over the forecast period owing to the large volume of assays performed as they are considered as the first line detection tests. Imaging is a supportive examination for confirmation of inflammation in the liver. Whereas the liver biopsy is performed in chronic conditions for confirmation of virus type. It is also used for clinical detection and occurrence of cancerous cells in the liver triggered by the hepatitis virus infection.

The liver function profiling involves measurement of liver chemical components such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), bilirubin, alkaline phosphate and gamma glutamyl transferase (GGT). The liver function test is the first marker in the diagnosis of liver diseases. Further the specific assays can be performed for confirmation of specific type of viral infection. This segment dominates the blood tests and is also expected to be the fastest growing segment over the forecast period.

Global hepatitis diagnostics market

Furthermore, immunoassays involve number of simple and rapid tests and assays specific to virus type, namely HAV IgM, HBsAg, HBcAb Total, HBcAb IgM, HDV Ab Total, HDV IgM, and HCV Ab. These tests involve detection of antigen and antibodies specific to various hepatitis viruses. Furthermore, the molecular diagnostic procedures such as HBV DNA and HCV RNA specific to DNA and RNA mutation in the detection of virus type B & C are commercially available. The detection and interpretation of these tests involves usage of high end sophisticated technology such as ELISA/EIA, RIBA, CLIA and PCR systems. However, these tests are more expensive compared to the liver function tests. Thus, these tests are anticipated to grow at a slower pace over the forecast period.

Regional Insights

North America is the most mature market for diagnostic tests which is followed by Europe. Owing to high prevalence rate and various government initiatives creating awareness regarding rising incidences, treatment and diagnostic test options for the diseases and developed healthcare infrastructure is boosting the growth of the regional market

Canada market is expected to experience accelerated growth as a result of the initiatives by the government agencies such as World Hepatitis Day by The Public Health Agency of Canada in order to create awareness regarding detection. These initiatives are pushing the demand for diagnostic tests in the country.

Asia Pacific is expected to emerge as the fastest growing market in the global market. Hepatitis E virus is more common in East and South Asia compared to other parts of the world. According to the Global Hepatitis Report 2017, report by WHO, the prevalence of HEP type B in South East Asia is around 0.7% and the incidence rate for HCV infection is 14.7 in 1,000,000 people. It also states some of the factors such as vital spread of diseases, unprotected sex, and transfer of fluid from the infected person are contributing to the rise in burden of hepatitis in the region which are creating growth opportunities.

Hepatitis Diagnostic Market Share Insights

The key players of the market include Abbott Laboratories; Danaher Corporation; F. Hoffmann Roche; DiaSorin S.p.A; MedMira, Inc.; Siemens Ag, and bioMeriuex. The market also includes other players such as Hologic, Inc.; and Bio Rad Laboratories, etc. These players hold a strong position in market with their strategic initiatives such as mergers and acquisitions, partnerships with small/local players to expand their geographic foothold and widening of product portfolio by sharing the technology and products. 

Report Scope



Base year for estimation


Actual estimates/Historical data

2014 - 2015

Forecast period

2017 - 2025

Market representation

Revenue in USD Million & CAGR from 2017 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America& MEA

Country scope

U.S., Canada, UK, Germany, China, Japan, Brazil, Mexico, & South Africa

Report coverage

Revenue, company share, competitive landscape, growth factors, trends

15% free customization scope (equivalent to 5 analysts working days)

If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the hepatitis diagnostics market report on the basis of test types, and region:

  • Diagnostic Tests Outlook (Revenue, USD Million; 2014 - 2025)

    • Blood tests

      • Liver function tests

      • Immunoassays

      • Nucleic Acid Tests

    • Imaging Tests

    • Liver Biopsy

  • Regional Outlook (Revenue, USD Million; 2014 - 2025)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • UK

    • Asia Pacific

      • China

      • Japan

    • Latin America

      • Mexico

      • Brazil

    • MEA

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $7,950
BI Library Access - $9,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified